Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients

The local immune-inflammatory response elicited by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is still poorly described, as well as the extent to which its characteristics may be associated with the outcome of critical Coronavirus disease 2019 (COVID-19). In this prospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Voiriot, Guillaume, Dorgham, Karim, Bachelot, Guillaume, Fajac, Anne, Morand-Joubert, Laurence, Parizot, Christophe, Gerotziafas, Grigorios, Farabos, Dominique, Trugnan, Germain, Eguether, Thibaut, Blayau, Clarisse, Djibré, Michel, Elabbadi, Alexandre, Gibelin, Aude, Labbé, Vincent, Parrot, Antoine, Turpin, Matthieu, Cadranel, Jacques, Gorochov, Guy, Fartoukh, Muriel, Lamazière, Antonin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178326/
https://www.ncbi.nlm.nih.gov/pubmed/35681070
http://dx.doi.org/10.1038/s41598-022-13179-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178326/
https://www.ncbi.nlm.nih.gov/pubmed/35681070
http://dx.doi.org/10.1038/s41598-022-13179-0

Ejemplares similares